Overall rank by patents
#743
of 49,997 tracked assignees
USPTO PatentsView assignee record - 615 granted patents across 125 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Fresenius ranks #743 of 49,997 tracked US assignees by granted-patent volume, with 615 patents across 125 technology areas.
USPTO PatentsView assignee plate
Corpus R743 · Foreign Corporation #743 · 615 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Bell Helicopter Textron Inc. (±1 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Abb Vie · near
63 score
Augustine Biomedical… · near
63 score
Dana Heavy Vehicle… · near
63 score
Fresenius Medical… · this assignee
63 score
Korea Institute OF… · near
63 score
3D Lighting… · lowest
7 score
What this shows Fresenius's Innovation Score is 63.2/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Fresenius Medical Care Deutschland GmbH received 276 grants versus 297 in 2015–2019 (-7% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2017 at 67 grants and bottomed in 2023 at 37. Lead class A61M accounts for 87.6% of the portfolio across 125 subclasses. Volume neighbours: InvenSense, Inc. (#739) and Spectrum Brands, Inc. (#747).
From 2019–2021 to 2022–2024, Fresenius Medical Care Deutschland GmbH moved from 176 to 167 grants (0.95x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,322. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
InvenSense, Inc.
617 patents
Bell Helicopter Textron Inc.
616 patents
Suzuki Motor Corporation
616 patents
Uchicago Argonne, LLC
616 patents
Fresenius Medical Care Deutschland GmbH
615 patents
Dexerials Corporation
614 patents
Allergan, Inc.
612 patents
Ford Motor Company
612 patents
Spectrum Brands, Inc.
612 patents
What this shows Fresenius holds 615 patents at rank #743, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #743 in granted patent volume.
Other assignees with the most granted patents in Fresenius's primary technology class.
Two PlainPatent-derived peer sets for Fresenius, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (63 here).
Nearest assignees by average claims per patent (16.1 here).
Fresenius's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 46 | 7.5% |
| 2016 | 65 | 10.6% |
| 2017 | 67 | 10.9% |
| 2018 | 52 | 8.5% |
| 2019 | 67 | 10.9% |
| 2020 | 60 | 9.8% |
| 2021 | 49 | 8.0% |
| 2022 | 63 | 10.2% |
| 2023 | 37 | 6.0% |
| 2024 | 67 | 10.9% |
| 2025partial year | 42 | 6.8% |
Top 15 of 125 technology areas
Overall rank by patents
#743
of 49,997 tracked assignees
63.2 out of 100
What to do with this data
Fresenius Medical Care Deutschland GmbH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.